CLSI I/LA34 A : 1ED 2011
Withdrawn
A Withdrawn Standard is one, which is removed from sale, and its unique number can no longer be used. The Standard can be withdrawn and not replaced, or it can be withdrawn and replaced by a Standard with a different number.
DESIGN AND VALIDATION OF IMMUNOASSAYS FOR ASSESSMENT OF HUMAN ALLERGENICITY OF NEW BIOTHERAPEUTIC DRUGS
Hardcopy
30-06-2011
English
30-06-2011
Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Biochemical and Clinical Properties of IgE
6 Utility of IgE in Clinical Studies of Drug
Safety and Efficacy
7 Specimens
8 Assay Protocols
9 Qualification of Assay Reagents
10 Validation and Testing Strategy
11 Assay Interference
12 Recommendations for Drug Manufacturers
13 Recommendations for Academic Centers
and Practitioners Monitoring Immunogenicity
in Clinical Trials
14 Recommendations for Regulators
References
Appendix A - Drug Allergen Specificities Available
for IgE Antibody Testing in Commercial Assays
Appendix B - Protocol for Depletion of IgE and IgM
Antibodies From Human Serum
Appendix C - Illustrative Protocol Enzyme-Linked
Immunosorbent Assay for IgE Antidrug Detection
in Human Serum
The Quality Management System Approach
Related CLSI Reference Materials
Important note : All end users must be registered with an Account prior to user licenses being assigned.Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.